Veradermics, Incorporated

Market Cap

$4B

Healthcare·Biotechnology·🇺🇸 United States·NYSE

Healthcare·Biotechnology·🇺🇸·NYSE

Stock Price

$90.32+$52.57 (+139.26%)

Jun 8, 2026

52W High $114.8052W Low $37.03

Company Details

Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. ...

CEO

—

IPO Date

Feb 4, 2026

Website

www.veradermics.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$67M

EPS (Diluted)

Free Cash Flow

-$62M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q2 2026

Aug 13, 2026

PENDING

Q1 2026

May 15, 2026

FY 2025

Mar 30, 2026

Q4 2025

Mar 30, 2026

Q1 2025

Mar 31, 2025

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee